Rattlesnake serum could reinvent fight against deadly venoms
Recent research shows that combinations of FETUA proteins from western diamondback rattlesnakes can neutralise rattlesnake venom lethality in mice with significantly higher potency than commercial antivenoms. Because rattlesnakes are immune to their own venom and possess toxin sponges in their bloodstreams, scientists explored these proteins as a broad-spectrum antidote. The study demonstrated that FETUA protein combinations could neutralize multiple dangerous pit viper venoms. If successfully translated into clinical practice, this discovery could lead to next-generation antivenoms that offer cross-species protection against multiple snake species without relying on traditional animal-derived immunisation.
Key Points
- FETUA proteins from western diamondback rattlesnakes have shown high potency in neutralizing various snake venoms.
- Rattlesnakes use specific blood proteins and toxin sponges to remain immune to their own venom.
- The proposed antivenom approach could offer broad-spectrum protection against multiple pit viper species.
- This recombinant protein approach aims to bypass the need for traditional animal immunization methods.
Exam Facts
- Rattlesnakes have evolved these defensive proteins for 50 million years.
- The study tested combinations against C. atrox venom, the Malayan pit viper, and the Chinese moccasin.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.